Company intelligence / Profile preview
Kyntra Bio
San Francisco, California, United Stateskyntrabio.com ↗
- Ownership
- Public · KYNB
- Employees
- ~225
- Development stage
- Other
01
Overview
Kyntra Bio, formerly known as FibroGen, is a clinical-stage biopharmaceutical company focused on developing innovative therapies for oncology and rare diseases. Following a strategic rebranding in early 2026, the company shifted its focus toward mid- and late-stage assets, including roxadustat, a first-in-class small molecule treatment for anemia. Its lead oncology program is FG-3246, an antibody-drug conjugate (ADC) targeting CD46, currently in Phase 2 development for metastatic castration-resistant prostate cancer. The company is also advancing a pipeline of novel checkpoint inhibitors and imaging agents, leveraging its legacy expertise in hypoxia biology and monoclonal antibodies. Kyntra Bio is headquartered in San Francisco and is publicly traded on the Nasdaq.
- Therapeutic areas
- HematologyNephrologyOncology
- Modalities
- Small moleculeAntibody-drug conjugateMonoclonal antibodyRadiopharmaceutical
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
04
Financials
- Market cap
- $14.8M
- Total revenue
- $6.4M
- Enterprise value
- $-76.5M
Beyond the preview
Go deeper on Kyntra Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kyntra Bio.